Difference between revisions of "Part:BBa K3582103"
Line 20: | Line 20: | ||
<span class='h3bb'>Sequence and Features</span> | <span class='h3bb'>Sequence and Features</span> | ||
<partinfo>BBa_K3582103 SequenceAndFeatures</partinfo> | <partinfo>BBa_K3582103 SequenceAndFeatures</partinfo> | ||
+ | |||
+ | ===References=== | ||
+ | 1] Lau, C.K.Y., Turner, L., Jespersen, J.S., Lowe, E.D., Petersen, B., Wang, C.W., Petersen, J.E.V | ||
+ | Lusingu,J., Theander, T.G., Lavstsen, T., Higgins, M.K. (2015) Cell Host Microbe 17: 118 | ||
+ | DOI: 10.2210/pdb4V3E/pdb | ||
Latest revision as of 15:23, 20 October 2020
Inhibitory Sequence 1 for PfEMP1-EPCR interaction
The following characteristic properties are observed in the inhibitory peptide sequence:
- 1] Interaction Energy:-15.7467 kcal/mol
- 2] Stability Value: 8.03145 dGunits
This bio brick synthesizes the inhibitory peptide sequence that is believed to bind more efficiently as Compared to the wild type sequence. The peptide sequence is built using saturated mutagenesis. In this particular mutant sequence, the amino acid of the Wild type sequence-Leucine(L) is replaced with Tryptophan(W). As a result, an upgradation in its interactive properties is observed that is thought to improve its binding strength.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
References
1] Lau, C.K.Y., Turner, L., Jespersen, J.S., Lowe, E.D., Petersen, B., Wang, C.W., Petersen, J.E.V Lusingu,J., Theander, T.G., Lavstsen, T., Higgins, M.K. (2015) Cell Host Microbe 17: 118 DOI: 10.2210/pdb4V3E/pdb